
Acalnib Acalabrutinib 100 mg Capsules are an oral targeted therapy used for the treatment of certain blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
| Composition | Acalabrutinib |
| Manufacturer | Hetero |
| Packing | 30 Capsules |
| Prescribed For | Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma |
| Expiry | December 2027 |




Order Acalnib (Acalabrutinib 100 mg Capsules, Calquence) at discounted rates from our trusted and licensed generic pharmacy. We are a reputed pharmaceutical wholesaler and exporter, supplying approved generic anticancer medications in bulk to patients, hospitals, physicians, clinics, and healthcare professionals in over 80 countries, including Colombia, Venezuela, Panama, Peru, the Philippines, Ecuador, Namibia, Cyprus, Egypt, Iran, South Africa, Zimbabwe, Bahrain, Iraq, Israel, Saudi Arabia, the UAE, Jordan, Palestine, Qatar, China, Malaysia, Singapore, Vietnam, Canada, Brazil, Mexico, Russia, Thailand, South Korea, Taiwan, Indonesia, the United States, and many others.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
Special pricing and offers available for bulk or long-term prescription purchases.
We source medicines directly from certified pharmaceutical manufacturers.
We support reshipments or refunds for undelivered, damaged, or incorrect orders.
Place your order through our website, WhatsApp, email, or by calling from anywhere in the world.
We coordinate with prescribing doctors (if needed) to ensure proper compliance and safety.
Customer care is available in English, Spanish, Russian, and other regional languages to assist global clients.